Theorem names VP, global business development

Thursday, October 27, 2011 12:22 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Adam Serody vice president, global business development. In his new role, Serody will lead Theorem’s global sales, proposals and marketing organizations.

Most recently, Serody served as executive director of business development and global leader for phase IV at Pharmanet.

“His clinical background, proven sales track record, and expertise in driving marketing and proposals efforts provide Adam with a unique perspective on every aspect of not only the sales cycle, but also the clinical development cycle. With Adam leading our team, I believe we will be uniquely positioned for future success,” said John Potthoff, PhD, president and CEO of Theorem.




Browse by:


September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs